New Map Shows CDC Investments to Fight AR

Explore antimicrobial resistance (AR) investments in your state

Updated Map Shows CDC’s Investments to Fight Antimicrobial Resistance Explore activities happening in your state or country

Today, CDC released the updated Antimicrobial Resistance (AR) Investment Map, highlighting CDC’s AR funding to global and domestic partners—from academic centers to local public health departments. These partners work alongside CDC to implement innovative solutions to slow the spread of AR, improve infection prevention and control (IPC), and protect people. CDC’s investments have strengthened U.S. and global capacities to rapidly detect, respond to, and contain existing and emerging AR threats.

Each year, more than 3 million people get an antimicrobial-resistant infection or Clostridioides difficile infection (often associated with taking antibiotics). In fiscal year 2022, CDC invested more than $120 million of annual funding to support health departments and partners in the United States and abroad to combat and prevent antimicrobial-resistant infections. CDC also invested more than $900 million from temporary supplemental funding to fight a range of infections that threaten the nation’s health, including those caused by AR organisms, COVID-19, and other known and emerging infectious diseases. However, when supplemental funds end, CDC will not be able to continue supporting work at the level shown in the current AR Investment Map. This will risk progress in combating AR and strengthening IPC and outbreak response across One Health.

Highlights of this year’s AR Investment Map release include: An interactive map showcasing CDC’s AR funding to support activities in every U.S. state health department and across hundreds of public health partners An updated fact sheet featuring CDC’s global investments with partners in more than 50 countries to improve detection, prevention, and response to AR threats internationally An updated fact sheet showing how CDC’s COVID-19 supplemental funding has supported efforts that also address AR, including investments in IPC; training and capacity building, such as Project Firstline; surveillance; and public health personnel CDC leads the U.S. public health response to combat AR, a threat that continues to emerge and spread across the world. CDC’s AR Solutions Initiative invests in national infrastructure to detect, respond to, contain, and prevent resistant infections across healthcare settings, communities, the food supply, and the environment (water, soil).

	Germs can spread quickly across countries and continents. #CDCfightsAR with millions in investments to support lab, epi, and innovation in the U.S. & more than 50 countries this year: https://bit.ly/ARInvestMap

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe